Formation of an adduct by clenbuterol, a β-adrenoceptor agonist drug, and serum albumin in human saliva at the acidic pH of the stomach: Evidence for an aryl radical-based process

Free Radical Biology and Medicine

Volumn 45, Issue 2, 2008, Pages 124-135

  Pietraforte, D ^a   Brambilla, G ^a   Camerini, S ^a   Scorza, G ^a   Peri, L ^a   Loizzo, A ^a   Crescenzi, M ^a   Minetti, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

2 agonists; Arenediazonium ion; Aryl radical; Clenbuterol; Free radicals; Human saliva; Nitric oxide; Nitrite; Nitrosocompounds; Serum albumin

Indexed keywords

ALBUMIN; ANTIBODY; ARENEDIAZONIUM; ASCORBIC ACID; CLENBUTEROL; CLENBUTEROL ANTIBODY; GLUTATHIONE; NITRATE; NITRIC OXIDE; NITRITE; NITROUS ACID; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; TYROSINE;

ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; HUMAN; PH MEASUREMENT; PRIORITY JOURNAL; SALIVA; STOMACH JUICE; STOMACH PH;

ADRENERGIC BETA-AGONISTS; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLENBUTEROL; ELECTRON SPIN RESONANCE SPECTROSCOPY; GASTRIC JUICE; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; NITRO COMPOUNDS; NITROSATION; SALIVA; SERUM ALBUMIN, BOVINE; SPECTROPHOTOMETRY; STOMACH;

ANIMALIA;

EID: 44649152907     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.03.018     Document Type: Article

References (65)

1. Teng Y.D., Choi H., Huang W., Onario R.C., Frontera W.R., Snyder E.Y., and Sabharwal S. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 397 (2006) 155-158
2. Kuiper H.A., Noordam M.Y., van Dooren-Flipsen M.M., Schilt R., and Roos A.H. Illegal use of beta-adrenergic agonists: European Community. J. Anim. Sci. 76 (1998) 195-207
3. Tollefson L. In reply to: Food poisoning following consumption of clenbuterol-treated veal in Italy. J. Am. Med. Assoc. 278 (1997) 635
4. Bartsch H., and O'Neill I.K. Eighth International Meeting on N-Nitroso Compounds: occurrence, biological effects and relevance to human cancer. Cancer Res. 44 (1984) 1301-1304
5. Bartsch H., and Montesano R. Relevance of nitrosamines to human cancer. Carcinogenesis 5 (1984) 1381-1393
6. Brambilla G., and Martelli A. Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicity. Lancet Oncol. 6 (2005) 538-539
7. Brambilla G., and Martelli A. Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products. Mutat. Res. 635 (2007) 17-52
8. International Agency for Research on Cancer. Overall evaluation of carcinogenicity: an updating of IARC monographs. W.H.O. International Agency for research on cancer. Monographs on the Evaluation of the Carcinogenic Risks to Humans Volumes 1 to 42 (1987), Lyon, (France) Supplement 7
9. Bjorne H., Petersson J., Phillipson M., Weitzberg E., Holm L., and Lundberg J.O. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J. Clin. Invest. 113 (2004) 106-114
10. Sander J., and Seif F. Bakterielle: reduction von Nitrat im Magen des Menschen als ursache einer Nitrosamin-Bildung. Arzneim.-Forsch. 19 (1969) 1091-1093
11. Dykhuizen R., Frazer R., Duncan C., Smith C., Golden M., Benjamin N., and Leifert C. Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense. Antimicrob. Agents Chemother. 40 (1996) 1422-1425
12. Dykhuizen R.S., Fraser A., McKenzie H., Golden M., Leifert C., and Benjamin N. Helicobacter pylori is killed by nitrite under acidic conditions. Gut 42 (1998) 334-337
13. Desai K.M., Sessa W.C., and Vane J.R. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351 (1991) 477-479
14. Tottrup A., Ny L., Alm P., Larsson B., Forman A., and Andersson K.E. The role of the l-arginine/nitric oxide pathway for relaxation of the human lower oesophageal sphincter. Acta Physiol. Scand. 149 (1993) 451-459
15. Hasse H.H.L. In: Hanrahan J.P. (Ed). Beta agonists and their effects on animal growth and carcass quality (1988), Elsevier, New York 13
16. Kearns C.F., McKeever K.H., Malinowski K., Struck M.B., and Abe T. Chronic administration of therapeutic clenbuterol acts as a repartitioning agent. J. Appl. Physiol. 91 (2001) 2064-2070
17. Martinez-Navarro J.F. Food poisoning related to consumption of illicit β-agonist in liver. Lancet 336 (1990) 1311
18. Shiu T.C., and Chong W.H. A cluster of clenbuterol poisoning associated with pork and pig offal in Hong Kong. Public Health Epidemiol. Bull. 10 (2001) 14-17
19. Xinhua. More than 300 people poisoned by pig-feed additive in Shanghai. http://english.people.com.cn/200609/16/eng20060916_303281.html 2006.
20. Salleras L., Dominguez A., Mata E., Taberner J.L., Moro I., and Salva P. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep. 110 (1995) 338-342
21. Brambilla G., Loizzo A., Fontana L., Strozzi M., Guarino A., and Soprano V. Food poisoning following consumption of clenbuterol-treated veal in Italy. J. Am. Med. Assoc. 278 (1997) 635
22. Zimmer A. Single and multiple applications and metabolite pattern of clenbuterol in man. Arzneimittelforschung 26 (1976) 1446-1450
23. Yamamoto I., Iwata K., and Nakashima M. Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit. J. Pharmacobiodyn. 8 (1985) 385-391
24. Couet W., Girault J., Reigner B.G., Ingrand I., Bizouard J., Acerbi D., Chiesi P., and Fourtillan J.B. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation. Int. J. Clin. Pharmacol. Ther. Toxicol. 27 (1989) 467-472
25. Zalko D., Debrauwer L., Bories G., and Tulliez J. Metabolism of clenbuterol in rats. Drug Metab. Dispos. 26 (1977) 891-899
26. Kopitar Z., and Zimmer A. Comparison of the pharmacokinetic profiles of clenbuterol in rat and dog during toxicological studies. Arzneimittelforschung 26 (1976) 1450-1555
27. Zalko D., Debrauwer L., Bories G., and Tulliez J. Evidence for a new and major metabolic pathway of clenbuterol involving in vivo formation of an N-hydroxyarylamine. Chem. Res. Toxicol. 10 (1997) 197-204
28. Montesissa C., Anfossi P., Biancotto G., and Angeletti R. In vitro metabolism of clenbuterol and bromobuterol by pig liver microsomes. Xenobiotica 28 (1998) 1049-1060
29. Zalko D., Perdu-Durand E., Debrauwer L., Bec-Ferte M.-P., and Tulliez J. Comparative metabolism of clenbuterol by rat and bovine liver microsomes and slices. Drug Metab. Dispos. 26 (1998) 28-35
30. Brambilla G., di Bez S., Pietraforte D., Minetti M., Campanella G., and Loizzo A. Ex vivo formation of gastric metabolites of clenbuterol: preliminary characterisation of their chemical structure. Anal. Chim. Acta 586 (2007) 426-431
31. Peri L., Pietraforte D., Scorza G., Napolitano A., Fogliano V., and Minetti M. Apples increase nitric oxide production by human saliva at the acid pH of the stomach: a new biological function for polyphenols with a catechol group?. Free Radic. Biol. Med. 39 (2005) 668-681
32. Kim Y.H., and Kim Y.S. Effects of active immunization against clenbuterol on the growth-promoting effect of clenbuterol in rats. J. Anim. Sci. 75 (1997) 446-453
33. Sangiorgi E., and Curatolo M. Application of a sequential analytical procedure for the detection of the beta-agonist brombuterol in bovine urine samples. J. Chromatogr., B, Biomed. Sci. Appl. 693 (1997) 468-478
34. Biondi P.A., Guidotti L., Montana M., Manca F., Brambilla G., and Lucarelli C. A derivatization procedure suitable for HPLC analysis of clenbuterol. J. Chromatogr. Sci. 29 (1991) 190-196
35. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., and Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from l-arginine. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8103-8107
36. Nagler R.M., Klein I., Zarzhevsky N., Drigues N., and Reznick A.Z. Characterization of the differentiated antioxidant profile of human saliva. Free Radic. Biol. Med. 32 (2002) 268-277
37. Sculley D.V., and Langley-Evans S.C. Salivary antioxidants and periodontal disease status. Proc. Nutr. Soc. 61 (2002) 137-143
38. Pietraforte D., Castelli M., Metere A., Scorza G., Samoggia P., Menditto A., and Minetti M. Salivary uric acid at the acidic pH of the stomach is the principal defense against nitrite-derived reactive species: sparing effects of chlorogenic acid and serum albumin. Free Radic. Biol. Med. 41 (2006) 1753-1763
39. Takahama U., Hirota S., and Oniki T. Production of nitric oxide-derived reactive nitrogen species in human oral cavity and their scavenging by salivary redox components. Free Radic. Res. 39 (2005) 737-745
40. Capurso G., Ricci R., Panzuto F., Baccini F., Passi S., Di Giulio E., Delle Fave G., and Annibale B. Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter 8 (2003) 300-306
41. Dabrowska-Ufniarz E., Dzieniszewski J., Jarosz M., and Wartanowicz M. Vitamin C concentration in gastric juice in patients with precancerous lesions of the stomach and gastric cancer. Med. Sci. Monit. 8 (2002) CR96-CR103
42. O'Connor H.J., Schorah C.J., Habibzedah N., Axon A.T., and Cockel R. Vitamin C in the human stomach: relation to gastric pH, gastroduodenal disease, and possible sources. Gut 30 (1989) 436-442
43. Mowat C., Carswell A., Wirz A., and McColl K.E. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 116 (1999) 813-822
44. da Silva G., Kennedy E.M., and Dlugogorski B.Z. Effect of added nucleophilic species on the rate of primary amino acid nitrosation. J. Am. Chem. Soc. 27 (2005) 3664-3665
45. Moore S., Calder K.A., Miller N.J., and Rice-Evans C.A. Antioxidant activity of saliva and periodontal disease. Free Radic. Res. 21 (1994) 417-425
46. Archer M.C., Tannenbaum S.R., Fan T.Y., and Weisman M. Reaction of nitrite with ascorbate and its relation to nitrosamine formation. J. Natl. Cancer Inst. 54 (1975) 1203-1205
47. Hart T.W. Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of l-cysteine and glutathione. Tetrahedron Lett. 26 (1985) 2013-2016
48. Halliwell B. Albumin-an important extracellular antioxidant?. Biochem. Pharmacol. 37 (1988) 569-571
49. Galli C. Radical reactions of arenediazonium ions: an easy entry into the chemistry of the aryl radical. Chem. Rev. 88 (1988) 765-795
50. Reszka K.J., and Chignell C.F. One-electron reduction of arenediazonium compounds by physiological electron donors generates aryl radicals: an EPR and spin trapping investigation. Chem. Biol. Interact. 96 (1995) 223-234
51. Costas-Costas U., Gonzalez-Romero E., and Bravo-Diaza C. Effects of ascorbic acid on arenediazonium salts reactivity: kinetics and mechanism of the reaction. Helv. Chim. Acta 84 (1995) 632-647
52. Knowles M.E., McWeeny D.J., Couchman L., and Thorogood M. Interaction of nitrite with proteins at gastric pH. Nature 247 (1947) 288-289
53. Natake M., and Ueda M. Changes in food proteins reacted with nitrite at gastric pH. Nutr. Cancer 8 (1986) 41-45
54. Gladwin M.T., Schechter A.N., Kim-Shapiro D.B., Patel R.P., Hogg N., Shiva S., Cannon III R.O., Kelm M., Wink D.A., Espey M.G., Oldfield E.H., Pluta R.M., Freeman B.A., Lancaster Jr. J.R., Feelisch M., and Lundberg J.O. The emerging biology of the nitrite anion. Nat. Chem. Biol. 1 (2005) 308-314
55. Bryan N.S. Nitrite in nitric oxide biology: cause or consequence?: A systems-based review. Free Radic. Biol. Med. 41 (2006) 691-701
56. Bjorne H., Weitzberg E., and Lundberg J.O. Intragastric generation of antimicrobial nitrogen oxides from saliva-physiological and therapeutic considerations. Free Radic. Biol. Med. 41 (2006) 1404-1412
57. Moriya A., Grant J., Mowat C., Williams C., Carswell A., Preston T., Anderson S., Iijima K., and McColl K.E. In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand. J. Gastroenterol. 37 (2002) 253-261
58. Suzuki H., Hijima K., Moriya A., McElroy K., Scobie G., Fyfe V., and McColl K.E. Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia. Gut 52 (2003)
59. Ross D., Norbeck K., and Moldeusg P. The generation and subsequent fate of glutathionyl radicals in biological systems. J. Biol. Chem. 260 (1985) 15028-15032
60. Hecht S.S., Carmella S.G., and Murphy S.E. Hemoglobin adducts as biomarkers of exposure to and metabolic activation of carcinogenic tobacco-specific nitrosamines. Biomed. Environ. Sci. 4 (1991) 93-103
61. Hecht S.S., Carmella S.G., Foiles P.G., Murphy S.E., and Peterson L.A. Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. Environ. Health Perspect. 99 (1993) 57-63
62. Falter B., Kutzer C., and Richter E. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Invest. 72 (1994) 364-371
63. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4003-4008
64. Augusto O. Alkylation and cleavage of DNA by carbon-centered radical metabolites. Free Radic. Biol. Med. 15 (1993) 329-336
65. Kato T., Kojima K., Hiramoto K., and Kikugawa K. DNA strand breakage by hydroxyphenyl radicals generated from mutagenic diazoquinone compounds. Mutat. Res. 268 (1992) 105-114